Hennessey, John C. (2015) Effect of proteinase-activated receptor 2 activating peptide, 2-furoyl-LIGRLO-amide, on murine mesenteric endothelial cell Ca²⁺-events. Masters thesis, Memorial University of Newfoundland.
[English]
PDF
- Accepted Version
Available under License - The author retains copyright ownership and moral rights in this thesis. Neither the thesis nor substantial extracts from it may be printed or otherwise reproduced without the author's permission. Download (2MB) |
Abstract
Proteinase-activated receptor 2 (PAR2)-mediated elevations of cytosolic Ca²⁺, induced by PAR2 agonist 2-furoyl-LIGRLO-amide (2fly), have been demonstrated in cell culture experiments. The properties of individual PAR2-mediated Ca²⁺-events in endothelial cells (EC) have yet to be described, and the role that these Ca²⁺-events play in the preservation of PAR2-mediated vascular reactivity in endothelial dysfunction is not understood. Male C57BL/6J (PAR2-WT) and PAR2 knockout (PAR2-KO) mice were implanted with sub-cutaneous micro-osmotic pumps containing either saline (control) or angiotensin II (endothelial dysfunction). Doses of angiotensin II were 1.5 mg/kg/day, control pumps were filled with 100 μl of saline. Imaged under spinning disk confocal microscopy, Fluo-4 loaded Ang II-treated ECs exhibited 21% and 23% attenuation in the density of ACh-evoked muscarinic (M₃)-mediated, Ca²⁺-events in PAR2-WT and PAR2-KO, respectively. 2fly-mediated Ca²⁺-events were unaffected by Ang II treatment. The density of Ca²⁺-release sites were reduced by IP3R inhibition using xestospongin-C and TRPV channel inhibition using ruthenium red. This study identified two populations of non-propagating Ca²⁺-events in murine mesenteric ECs: small peripheral and large-repeating transients. The study concluded that PAR2 Ca²⁺-signaling is preserved in the presence of endothelial dysfunction. Immunocytochemistry experiments of fixed and permeabilized ECs, on a line-scan confocal microscope, revealed that the distribution of eNOS was significantly attenuated with Ang II treatment. This reduction of eNOS in Ang II-treated ECs may contribute to the attenuation of resistance vessel relaxation in endothelial dysfunction.
Item Type: | Thesis (Masters) |
---|---|
URI: | http://research.library.mun.ca/id/eprint/8360 |
Item ID: | 8360 |
Additional Information: | Includes bibliographical references (pages 109-129) |
Keywords: | Endothelium, Vascular, Cardiovascular, PAR2, Calcium |
Department(s): | Medicine, Faculty of |
Date: | May 2015 |
Date Type: | Submission |
Library of Congress Subject Heading: | Vascular endothelium--Effect of drugs on; Immunocytochemistry--Technique; Intracellular calcium; Angiotensin II |
Medical Subject Heading: | Endothelium, Vascular--drug effects; Immunohistochemistry; Calcium Metabolism Disorders; Angiotensin II |
Actions (login required)
View Item |